SCHEMBL4253483

SCHEMBL4253483

NC(=O)c1oc2c(F)cc(F)cc2c1NC(=O)c1ccc(C(=O)O)o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.42
MAPT P10636 4/20 0.42
MAPK10 P53779 3/20 0.42
HSD17B10 Q99714 3/20 0.42
TSHR P16473 2/20 0.42
AHR P35869 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 2/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
POLB P06746 2/20 0.38
PKM P14618 2/20 0.38
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
S1PR2 O95136 1/20 0.35
S1PR4 O95977 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
KDM4E B2RXH2 2/20 0.35
GPR35 Q9HC97 4/20 0.35
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4259581 0.87 MAPT (0.53) TP53MAPTMAPK10HSD17B10TSHR
SCHEMBL13699829 0.86 S1PR4 (0.49) TP53MAPTMAPK10HSD17B10TSHR
SCHEMBL4255128 0.84 NPC1 (0.43) TP53MAPTMAPK10HSD17B10TSHR
SCHEMBL13700052 0.84 MAPT (0.39) TP53MAPTMAPK10HSD17B10TSHR
SCHEMBL13700045 0.84 MITF (0.44) TP53MAPTMAPK10HSD17B10TSHR
SCHEMBL4256297 0.83 MAPK10 (0.61) TP53MAPTMAPK10HSD17B10TSHR
SCHEMBL13699861 0.82 MAPT (0.62) TP53MAPTMAPK10HSD17B10TSHR
SCHEMBL13700228 0.82 SMYD3 (0.41) TP53MAPTMAPK10HSD17B10TSHR
SCHEMBL4257436 0.82 HTR2C (0.39) TP53MAPTMAPK10HSD17B10TSHR
SCHEMBL13699915 0.81 TP53 (0.50) TP53MAPTMAPK10HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F TP53 4721/4885MAPT 4025/4885MAPK10 3802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.